Cargando…
Fournier’s gangrene with dapagliflozin in a rural hospital: a case report
Sodium-glucose cotransporter 2 (SGLT2) inhibitors, which are used for treatment of type 2 diabetes, are associated with risk of urogenital infections. FDA issued a black box warning about multiple case reports of Fournier’s gangrene (FG) observed in patients taking SGLT2 inhibitors. FG is a type of...
Autores principales: | Elbeddini, Ali, Tayefehchamani, Yasamin, Davey, Michelle, Gallinger, Jodi, Hooda, Naushin, Aly, Ahmed, Erickson, Dawn, Lee, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852914/ https://www.ncbi.nlm.nih.gov/pubmed/33526523 http://dx.doi.org/10.1136/bcr-2020-237784 |
Ejemplares similares
-
A Case of Fournier’s Gangrene in a Patient Taking Canagliflozin for the Treatment of Type II Diabetes Mellitus
por: Elbeddini, Ali, et al.
Publicado: (2020) -
Development and evaluation of an online medication safety module for medical students at a rural teaching hospital: the Winchester District Memorial Hospital
por: Elbeddini, Ali, et al.
Publicado: (2021) -
PSUN259 A Severe Case of Fournier's Gangrene Associated With Dapagliflozin
por: Syed, Shumail, et al.
Publicado: (2022) -
LBSUN291 Fournier's Gangrene In A Diabetic Male Taking Dapagliflozin
por: Patel, Janki M, et al.
Publicado: (2022) -
Amid COVID-19 pandemic: Challenges with access to care for COPD patients
por: Elbeddini, Ali, et al.
Publicado: (2021)